HEC68498 Sodium

HEC68498钠盐

Report date: 2026/03/27 20:01:50
NME

Base Information

Drug NameHEC68498 Sodium
Drug Alias NameHEC-68498CT365-Na
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsSerine/threonine-protein kinase mTOR inhibitors
TargetsPI3-kinase class ISerine/threonine-protein kinase mTOR
Therapy Area/IndicationsSolid tumoursIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesHec Pharm Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesSunshine Lake Pharma Co LtdGuangdong Dongyangguang Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A